Staci D. Arnold

958 total citations
30 papers, 474 citations indexed

About

Staci D. Arnold is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Staci D. Arnold has authored 30 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Pediatrics, Perinatology and Child Health and 13 papers in Hematology. Recurrent topics in Staci D. Arnold's work include Hemoglobinopathies and Related Disorders (15 papers), Prenatal Screening and Diagnostics (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Staci D. Arnold is often cited by papers focused on Hemoglobinopathies and Related Disorders (15 papers), Prenatal Screening and Diagnostics (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). Staci D. Arnold collaborates with scholars based in United States, Canada and Japan. Staci D. Arnold's co-authors include Monica Bhatia, Rodney R. Miles, Mitchell S. Cairo, James E. Herndon, Ann Bebe Guill, Leslie Forman, Zhezhen Jin, Lakshmanan Krishnamurti, Matt Hall and Prakash Satwani and has published in prestigious journals such as Blood, Annals of Internal Medicine and Neurology.

In The Last Decade

Staci D. Arnold

25 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Staci D. Arnold United States	11	220	162	141	134	85	30	474
Wasil Jastaniah Saudi Arabia	12	275 1.3×	163 1.0×	272 1.9×	95 0.7×	83 1.0×	64	623
Peder Skov Wehner Denmark	17	79 0.4×	292 1.8×	84 0.6×	107 0.8×	65 0.8×	46	620
Sanju Cyriac India	8	81 0.4×	63 0.4×	86 0.6×	94 0.7×	57 0.7×	22	343
Kala Y. Kamdar United States	14	69 0.3×	404 2.5×	55 0.4×	150 1.1×	113 1.3×	32	691
Kathrine Grell Denmark	15	62 0.3×	369 2.3×	132 0.9×	99 0.7×	50 0.6×	39	681
Anne M. Hall United States	6	72 0.3×	86 0.5×	303 2.1×	60 0.4×	39 0.5×	7	429
Moaath K. Mustafa Ali United States	12	43 0.2×	39 0.2×	117 0.8×	127 0.9×	59 0.7×	52	377
Nikita Mody‐Patel United States	10	478 2.2×	138 0.9×	480 3.4×	34 0.3×	18 0.2×	22	673
Stacy Cooper United States	12	33 0.1×	262 1.6×	87 0.6×	118 0.9×	35 0.4×	34	516
Alysia Bosworth United States	9	70 0.3×	137 0.8×	179 1.3×	182 1.4×	61 0.7×	45	429

Countries citing papers authored by Staci D. Arnold

Since Specialization

Citations

This map shows the geographic impact of Staci D. Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Staci D. Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Staci D. Arnold more than expected).

Fields of papers citing papers by Staci D. Arnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Staci D. Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Staci D. Arnold. The network helps show where Staci D. Arnold may publish in the future.

Co-authorship network of co-authors of Staci D. Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Staci D. Arnold. A scholar is included among the top collaborators of Staci D. Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Staci D. Arnold. Staci D. Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crosby, Lori E., Allison A. King, Jerlym S. Porter, et al.. (2025). Recommended measurement protocols for sickle cell disease in the PhenX toolkit: psychosocial factors and social determinants of health. PubMed. 2(1). yoaf019–yoaf019.

Guilcher, Gregory M.T., et al.. (2025). Healthcare costs associated with hematopoietic cell transplant for sickle cell disease in the United States and Canada: A comparative analysis. Blood. 146(Supplement 1). 6151–6151.

Stenger, Elizabeth, Staci D. Arnold, Akanksha Mehta, et al.. (2024). Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 30(9). 912.e1–912.e13.

Meacham, Lillian R., et al.. (2023). Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?. Transplantation and Cellular Therapy. 29(8). 531.e1–531.e4. 9 indexed citations

Szymczak, Julia E., Kelly Getz, Catherine Aftandilian, et al.. (2023). Child and family perceptions of satisfaction with neutropenia management in pediatric acute myeloid leukemia. Pediatric Blood & Cancer. 70(8). e30420–e30420. 2 indexed citations

Auger, Katherine A., Matt Hall, Samir S. Shah, et al.. (2023). Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 Pandemic. PEDIATRICS. 152(5). 15 indexed citations

Auger, Katherine A., Matt Hall, Staci D. Arnold, et al.. (2023). Identifying and Validating Pediatric Hospitalizations for MIS-C Through Administrative Data. PEDIATRICS. 151(5). 2 indexed citations

Horwitz, Edwin M., Benjamin Watkins, Kirsten M. Williams, et al.. (2022). Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation. Blood Advances. 6(10). 3058–3061. 4 indexed citations

Mupfudze, Tatenda, et al.. (2021). A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD). Transplantation and Cellular Therapy. 27(4). 345–351. 5 indexed citations

10.

Mupfudze, Tatenda, Jaime M. Preussler, Lih‐Wen Mau, et al.. (2021). Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease. Transplantation and Cellular Therapy. 27(8). 685.e1–685.e8. 2 indexed citations

11.

Elgarten, Caitlin W., Staci D. Arnold, Yimei Li, et al.. (2018). Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell Transplantation. Infection Control and Hospital Epidemiology. 39(7). 797–805. 5 indexed citations

12.

Szymczak, Julia E., Kelly Getz, Brian T. Fisher, et al.. (2017). Identifying patient‐ and family‐centered outcomes relevant to inpatient versus at‐home management of neutropenia in children with acute myeloid leukemia. Pediatric Blood & Cancer. 65(4). 6 indexed citations

13.

Arnold, Staci D., Zhezhen Jin, Monica Bhatia, et al.. (2017). Timing and Utility of Relapse Surveillance after Allogeneic Hematopoietic Cell Transplantation in Children with Leukemia. Biology of Blood and Marrow Transplantation. 23(4). 696–700. 2 indexed citations

14.

Shenoy, Shalini, Emanuele Angelucci, Staci D. Arnold, et al.. (2017). Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(4). 552–561. 55 indexed citations

15.

Jin, Zhezhen, Marc Foca, Justine M. Kahn, et al.. (2016). Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 22(9). 1646–1653. 31 indexed citations

16.

Ayyala, Rama S., Staci D. Arnold, Monica Bhatia, & Jahannaz Dastgir. (2016). Imaging findings in a child with calcineurin inhibitor-induced pain syndrome after bone marrow transplant for beta thalassemia major. Pediatric Radiology. 46(11). 1618–1621. 2 indexed citations

17.

Arnold, Staci D., Monica Bhatia, John Horan, & Lakshmanan Krishnamurti. (2016). Haematopoietic stem cell transplantation for sickle cell disease – current practice and new approaches. British Journal of Haematology. 174(4). 515–525. 32 indexed citations

18.

Satwani, Prakash, Ruta Brazauskas, Staci D. Arnold, et al.. (2015). A Study of Predictors of Clinical Outcomes and Healthcare Utilization in Children with Sickle Cell Disease Undergoing Allogeneic Hematopoietic Cell Transplantation. Blood. 126(23). 528–528. 4 indexed citations

19.

Arnold, Staci D., et al.. (2015). Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center Analysis. Biology of Blood and Marrow Transplantation. 21(7). 1258–1265. 33 indexed citations

20.

Arnold, Staci D., et al.. (2008). Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro-Oncology. 10(2). 171–181. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact